Unlock Your PTCB Dream: Ace the PTCE with Cutting-Edge CPhT Prep
According to federal law, a prescription for a Schedule IV controlled substance may be refilled a maximum of:
Correct : D
According tofederal law(Controlled Substances Act, CSA) andDrug Enforcement Administration (DEA) regulations, a prescription for aSchedule III or IV controlled substancemay be refilleda maximum of five (5) times within six (6) monthsfrom the date the prescription was written.
Refill Limit:A Schedule IV prescription may be refilled up to five (5) times within six (6) monthsfrom the issue date, if authorized by the prescriber.
Expiration:The prescription expiressix (6) monthsafter the date it was written.
Recordkeeping:The pharmacy must maintain accurate refill records either electronically or manually.
Additional Refills Beyond 5:If the patient needs refills after the 5-refill limit, anew prescriptionmust be issued by the prescriber.
Partial Fills:Partial dispensing is allowed, but the total quantity dispensed cannot exceed the originally prescribed amount.
A . 2 times in 3 months. Incorrect. Federal law allows more than 2 refills for Schedule IV drugs.
B . 3 times in 4 months. Incorrect. This underestimates the legal refill limit.
C . 4 times in 6 months. Incorrect. Schedule IV drugs may be refilledup to 5 times, not just 4, within 6 months.
DEA Pharmacist's Manual -- Controlled Substances Act (21 CFR 1306.22).
PTCB PTCE Exam Content Outline -- Federal Pharmacy Law and Controlled Substances.
FDA and DEA Guidelines on Schedule III-V Prescription Refills.
Mosby's Pharmacy Technician: Principles and Practice -- Controlled Substances Regulations.
Key DEA Rules for Schedule III and IV Prescriptions:Why the Other Answer Choices Are Incorrect:Pharmacy Technician Reference:
Start a Discussions
If M-M-R II antigen were inadvertently reconstituted with a stock vial of normal saline, pharmacy staff should:
Correct : D
TheM-M-R II (Measles, Mumps, and Rubella) vaccinemust bereconstituted only with the manufacturer-supplied diluentto maintain its efficacy and stability.
The manufacturer-provided diluent contains stabilizing agents that preserve the live attenuated virus.
Using normal saline can alter the pH and degrade the vaccine, making it ineffective.
The vaccine must be discarded if reconstituted incorrectlyand not administered.
A . Administer the vaccine as the diluents are equivalent.Incorrect
Normal saline is NOT equivalent to the manufacturer's diluentand can compromise the vaccine's potency.
B . Report the incident to the Drug Enforcement Administration (DEA).Incorrect
Vaccine errors should be reported to the CDC's Vaccine Adverse Event Reporting System (VAERS), not the DEA(which handles controlled substances, not vaccines).
C . Contact the Environmental Protection Agency (EPA) for guidance.Incorrect
The EPA regulates hazardous waste, not vaccine errors.The CDC or vaccine manufacturer should be contacted for guidance.
CDC Vaccine Storage and Handling Guidelines-- States thatvaccines must be reconstituted only with manufacturer-supplied diluents.
FDA Guidelines for M-M-R II Vaccine-- Confirms that improper reconstitutionrenders the vaccine ineffective.
PTCB PTCE Exam Content Outline-- Covers proper vaccine handling and error prevention.
Why Is Normal Saline Not an Acceptable Diluent?Why Not the Other Options?Key Reference:
Start a Discussions
Which of the following is theadverse event reporting programmaintained by theFDA?
Correct : C
MedWatch is the FDA's reporting system for adverse drug events, medication errors, and safety concerns.
Reference:FDA MedWatch Program.
Start a Discussions
A Class III recall:
Correct : D
TheFDA classifies recalls into three levels, withClass III being the least severe:
Class I RecallMost severe Issued when a drugmay cause serious harm or death.
Class II RecallModerate severity The drug may causetemporary or medically reversible adverse effects.
Class III RecallLeast severe The productis unlikely to cause harm but violates FDA regulations(e.g., labeling errors, minor packaging issues).
A . Is issued when there is a reasonable probability that the product will cause serious adverse health consequences or death.Incorrect
Describes a Class I recall, not Class III.
B . Is initiated by the FDA if a manufacturer has violated the adulteration provisions of the Food, Drug, and Cosmetic Act (FDCA).Incorrect
FDA action due to adulteration typically leads to Class I or Class II recalls, depending on severity.
C . Occurs when a product may cause temporary or medically reversible adverse health consequences.Incorrect
Describes a Class II recall, not Class III.
FDA Drug Recall Guidelines-- Defines Class I, II, and III recalls.
PTCB PTCE Exam Content Outline-- Covers recall classifications and pharmacy responsibilities.
FDA Enforcement Report-- Lists real-world examples of Class III recalls (e.g.,mislabeling, incorrect expiration dates).
Why Not the Other Options?Key Reference:
Start a Discussions
Which of the following statements regardingspecific patient medication returns in the hospital settingis correct?
Correct : C
Comprehensive and Detailed Step-by-Step Explanation:
Hospitals mayredispenseunopened, sealed, unit-dose medicationsreturned frominpatients, as long as they areproperly storedand not tampered with.
Explanation of Answer Choices:C. Unopened units-of-use returned from inpatients may be redispensedCorrect.Hospital pharmacies canredispense sealed unit-dose medications from inpatients.A. Unlabeled medications may be dispensed by the nurse at discharge Incorrect.Unlabeled meds cannot be dispensed due to safety concerns.B. Unopened units-of-use returned from outpatients may be redispensed Incorrect.Medications dispensed to outpatients cannot be returned to stock.D. Crediting of unused doses is not feasible Incorrect.Many hospitals have systems for crediting unused doses.
Reference:
USP <795> and <797>: Hospital Medication Storage
PTCB Medication Safety Regulations
Start a Discussions
Total 223 questions